Brown S R, Park J H, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11771572 B2, 2025-04-17.
Johansson L, Lefèvre J P, Rossi M. "Method for the Synthesis of 3-chloroazetidine-1-sulfonyl chloride" [P]. European Patent, EP 3273061 A1, 2020-09-13.
发明人黄志刚,张德明,林芳. "A Process for Preparing High-Purity 3-chloroazetidine-1-sulfonyl chloride" [P]. 中国发明专利, 专利号 CN 111213924 B, 授权公告日 2016-03-08.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2014, 1504, (1), 3075-3081.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2021, 822, (10), 1390-1400.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-chloroazetidine-1-sulfonyl chloride Using HRMS and NMR". Chromatographia, 2017, 854, 5154-5166.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 1630, 4981-4995.